GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Cyclically Adjusted PS Ratio

Coloplast AS (OCSE:COLO B) Cyclically Adjusted PS Ratio : 5.93 (As of Jul. 19, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS Cyclically Adjusted PS Ratio?

As of today (2025-07-19), Coloplast AS's current share price is kr606.20. Coloplast AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr102.18. Coloplast AS's Cyclically Adjusted PS Ratio for today is 5.93.

The historical rank and industry rank for Coloplast AS's Cyclically Adjusted PS Ratio or its related term are showing as below:

OCSE:COLO B' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.87   Med: 10.14   Max: 16.78
Current: 5.87

During the past years, Coloplast AS's highest Cyclically Adjusted PS Ratio was 16.78. The lowest was 5.87. And the median was 10.14.

OCSE:COLO B's Cyclically Adjusted PS Ratio is ranked worse than
73.65% of 482 companies
in the Medical Devices & Instruments industry
Industry Median: 2.325 vs OCSE:COLO B: 5.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Coloplast AS's adjusted revenue per share data for the three months ended in Mar. 2025 was kr30.745. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr102.18 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast AS Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Coloplast AS's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Cyclically Adjusted PS Ratio Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.58 13.55 8.96 8.09 8.87

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.74 8.62 8.87 7.87 7.08

Competitive Comparison of Coloplast AS's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted PS Ratio falls into.


;
;

Coloplast AS Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Coloplast AS's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=606.20/102.18
=5.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Coloplast AS's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=30.745/120.2000*120.2000
=30.745

Current CPI (Mar. 2025) = 120.2000.

Coloplast AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 16.577 100.300 19.866
201509 17.111 100.200 20.526
201512 17.150 99.800 20.656
201603 16.939 100.200 20.320
201606 17.337 100.600 20.715
201609 17.659 100.200 21.184
201612 17.703 100.300 21.215
201703 18.259 101.200 21.687
201706 18.427 101.200 21.887
201709 18.667 101.800 22.041
201712 18.597 101.300 22.067
201803 19.015 101.700 22.474
201806 19.920 102.300 23.406
201809 19.938 102.400 23.404
201812 20.319 102.100 23.921
201903 20.604 102.900 24.068
201906 21.617 102.900 25.251
201909 21.641 102.900 25.279
201912 22.093 102.900 25.807
202003 22.686 103.300 26.397
202006 20.699 103.200 24.109
202009 21.545 103.500 25.021
202012 22.276 103.400 25.895
202103 22.293 104.300 25.691
202106 22.671 105.000 25.953
202109 23.923 105.800 27.179
202112 24.239 106.600 27.331
202203 25.826 109.900 28.246
202206 27.498 113.600 29.096
202209 28.549 116.400 29.481
202212 28.743 115.900 29.809
202303 28.536 117.300 29.241
202306 28.715 116.400 29.652
202309 27.708 117.400 28.369
202312 29.425 116.700 30.307
202403 29.310 118.400 29.756
202406 30.627 118.500 31.066
202409 30.834 118.900 31.171
202412 31.185 118.900 31.526
202503 30.745 120.200 30.745

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast AS  (OCSE:COLO B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Coloplast AS Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines